博士，副教授，中华医学会眼科学分会青光眼学组委员，中国医师协会眼科医师分会青光眼专业委员会委员，湖北省医学青年拔尖人才，国家自然科学基金同行评审专家，现任三峡大学第一临床医学院副院长。
承担主要研究项目：
1、湖北省自然科学基金面上项目：视网膜小胶质细胞在青光眼视神经损害中的作用机制；2、湖北省卫计委青年人才项目：RGD多肽水凝胶的研制及其在青光眼造瘘术后抗瘢痕化的作用；
3、国家自然科学基金面上项目：RGD多肽水凝胶的研制及其在青光眼滤过术后抗瘢痕化的作用机制；
4、横向项目：5-FU RGD多肽水凝胶控释系统在青光眼滤过术后抗瘢痕化中的作用
主要研究成果:
在科研方面一直致力于青光眼术后抗瘢痕及视神经保护的机制研究，在新型生物材料RGD多肽水凝胶及抗代谢药物缓释系统方面有重大研究发现；对青光眼滤过道瘢痕化通路、青光眼视神经保护药物方面进行了系列研究。
1、视网膜小胶质细胞在青光眼视神经损害中的作用
2、改良青光眼滤过术后巩膜瓣、结膜瓣可调节缝线技术对青光眼滤过术后抗瘢痕化作用
3、首次实现Toll样受体4（TLR4）信号通路在眼部的抗瘢痕化应用
4、RGD多肽水凝胶合成
5、RGD多肽水凝胶载药后缓释系统的构建
6、鼠尾草酸对青光眼视神经保护作用
代表性论著
1.《Wills临床眼科彩色图谱及精要:青光眼》
2.Liang Liang, He Liye, Zhu Mengnan, Chen Baoji, Xiao Changyi, Protective effects of carnosic acid on retinal ganglion cells in acute ocular hypertension rats. International Ophthalmology. 2020 Apr 10
3.Ping Wu, Fang Duan, Chunhua Luo, Qiang Liu, Xingguang Qu,Liang Liang, Kaili Wu,Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019(COVID-19) in Hubei, China, JAMA Ophthalmology, 2020
4.Liang Liang, Wu Ping, There may be virus in conjunctival secretion of patients with COVID-19,Acta Ophthalmol. 2020 Mar 18.
5.Liang Liang, Zhu Mengnan, Chen Baoji,Wang Zeng,He Liye,Zhang Ran,Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes.Int J Ophthalmol. 2019 Nov 18;12(11):1699-1707.
6.Liang Liang,Zhang Ran, He Liye. Corneal Hysteresis and Glaucoma. Int Ophthalmol, 2018 Sep 5.
7.liang liang,liqinghua, jinkun, et al. In Vitro and In Vivo Evaluation of a Novel Ocular Delivery System of 5-Fluorouracil Peptide Hydrogel. Asian Journal of Chemistry. Vol.26,No.10(2014)
8.Xing-Hua Wang, Shuang Li,Liang Liang*, Xiao-Ding Xu, Xian-Zheng Zhang, Fa-Gang Jiang. Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye, Journal of Biomaterials Science, Polymer Edition. 24(10): 1185-97, 2013.
9.Li, W; Chen, WJ; Liu, W;Liang L;Zhang, MC. Homemade lyophilized cross linking amniotic sustained-release drug membrane with anti-scarring role after filtering surgery in rabbit eyes. International Journal of ophthalmology. 5 (5), 555-561, 2012
10.Xiao-Ding Xu,Liang Liang,Han Cheng,Xin-Hua Wang,Fa-Gang Jiang,Ren-Xi Zhuo, Xian-Zheng Zhang. Construction of therapeutic glycopeptide hydrogel as a new substitute for antiproliferative drugs to inhibit postoperative scarring formation. Journal of Materials Chemistry, 22: 18164-18171,2012
11.Liang Liang,Jun Yang, Qing-Hua Li, Ming Huo, Fa-Gang Jiang, Xiao-Ding Xu, Xian-Zheng Zhang. A Novel Targeting Drug Delivery System Based on Self-assembled Peptide Hydrogel, Journal of Biomaterials and Nanobiotechnology. 2: 622-625, 2011
12.Xiao-Ding Xu,Liang Liang,Chang-Sheng Chen, Bo Lu, Na-Ling Wang, Fa-Gang Jiang, Xian-Zheng Zhang, Ren-Xi Zhou. Peptide hydrogel as an intraocular drug delivery system for inhibition of postoperative scarring formation, ACS Appl Mater & Interfaces. 2(9): 2663-2671, 2010
13.Liang L, Xu XD, Zhang XZ, Feng M, Peng C, Jiang FG. Prevention of filtering surgery failure by subconjunctival injection of a novel peptide hydrogel into rabbit eyes, Biomed Mater. 5:045008, 2010
14.Liang L,Xu XD, Chen CS, Fang JH, Jiang FG, Zhang XZ, Zhou RX. Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye, J Biomed Mater Res B Appl Biomater. 93:324-32, 2010
15.何理烨,梁亮,朱梦男.鼠尾草酸在急性高眼压视神经损害中的保护作用[J].中华实验眼科杂志.2018,36(04):278-282
16.何理烨,梁亮,朱梦男.角膜滞后量在青光眼诊断和治疗中的应用价值.中华眼科杂志. 2017. 53(2)：140-143
17.朱梦男,梁亮,何理烨.纳米技术在青光眼诊断和治疗中的应用.眼科新进展. 2016. (10)：988-992
18.何理烨,梁亮,刘帅. RAPD在青光眼早期诊断中的应用.眼科新进展. 2016. (06): 596-600